CD223, Human (Relatlimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Search, find, compare suppliers for anti-CD223, Human (Relatlimab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD223, Human (Relatlimab biosimilar) |
| Clone | Relatlimab |
| Host Species | Recombinant |
| Reactive Species | human |
| Isotype | IgG4 kappa |
| Format | purified |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Applications | n/a |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-Human CD223 Recombinant Antibody (Relatlimab). Relatlimab (INN, development code BMS-986016) is a monoclonal antibody designed for the treatment of melanoma. This drug is being developed by Bristol-Myers Squibb. As of 2018, relatlimab is undergoing Phase II/III trials. |
| Immunogen | n/a |
| Other Names | Anti-CD223 Recombinant Antibody, Research Grade Relatlimab, Anti-Human CD223 Recombinant Antibody(Relatlimab), BMS-986016, ONO-4482, Antibody Drug Analogues, Monoclonal Antibody, YR1487, Research Grade Biosimilars, Biosimilar Antibody |
| Gene, Accession # | CAS: 1673516-98-7 |
| Catalog # | YR1487 |
| Price | please inquire |
| Order / More Info | CD223, Human (Relatlimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
| Product Specific References | n/a |
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806
info@kmdbioscience.com
Sales: sales@kmdbiosci.com
https://www.kmdbioscience.com
Profile of KMD BIOSCIENCE CO. LTD.